VisiQuate Announces Deployment of AI-based Analytics for Fresenius Medical Care

SANTA ROSA, Calif., Jan. 23, 2020 /PRNewswire/ — VisiQuate Inc. is pleased to announce that Fresenius Medical Care North America (FMCNA) has expanded a pilot program into a system-wide deployment of two of VisiQuate’s leading analytics solutions: Denials Management Analytics and Denial Flo. FMCNA is the leading provider of kidney care products and services including life-sustaining dialysis treatment for patients with kidney failure.

“When we first talked to the revenue cycle team at Fresenius Medical Care, it was clear they were ready to move to the next level,” VisiQuate’s co-Founder and Chief Experience Officer Rich Waller said. “They did some research, and quickly realized our Denial Flo solution could be ideal for them, because of the way it intelligently segments denials into prioritized worklists and assigns each account to the employee who could most effectively convert it into a paid claim.” 

As an evidence-based organization, FMCNA decided to begin with a 90-day pilot of VisiQuate’s Denial Flo solution. They began to see measurable results in a very short time, including enthusiastic adoption by their users, who were impressed by the ways it made them more productive. As a result, FMCNA decided to move ahead with the full deployment of Denial Flo, and added VisiQuate Denials Management Analytics, as well.

“One of our strongest advantages is speed to value,” Brian Robertson, VisiQuate’s Founder and CEO, said. “The time, collaboration, and enthusiasm that Fresenius Medical Care put into this collaboration is a key reason why our pilot went so well.”

About VisiQuate

Founded in 2009, VisiQuate, Inc. is an expert managed service that helps clients accelerate the enterprise-wide growth of business health more effectively than any other alternative. The company’s enterprise-scale Business Analytics integrate and simplify complex Big Data from multiple sources and present it as insights and actionable workflows. Hidden root causes, trends, and opportunities become clear, and lead directly to real-world results. For users at all levels, the app-like visualizations feel more retail than corporate. VisiQuate’s automated data assistant, Ana, uses artificial intelligence and machine learning to make users more productive. VisiQuate clients also benefit from the collective experience of industry domain leaders who help them achieve the best performance outcomes. The company is headquartered in Santa Rosa, CA.  For more information, visit www.visiquate.com or contact info@visiquate.com

Media contact:
Joy DiNaro
Amendola Communications for VisiQuate
(847) 809-0406
jdinaro@acmarketingpr.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/visiquate-announces-deployment-of-ai-based-analytics-for-fresenius-medical-care-300991933.html

SOURCE VisiQuate

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

14 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

14 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago